ALNY
Alnylam Pharmaceuticals (ALNY) Investor Questions
Review Alnylam Pharmaceuticals (ALNY) faq with company data, supporting context and links to related investor research.
Research record updated: . Individual measures may refer to different reporting periods.
- Company
- Alnylam Pharmaceuticals
- Sector
- Healthcare
- Industry
- Biotechnology
- Overall BTI score
- 87
- Annual revenue
- $3.71B
- Annual net income
- $313.75M
- Annual free cash flow
- $465.38M
Alnylam Pharmaceuticals (ALNY) Investor Questions research
Alnylam Pharmaceuticals trades under the ticker ALNY. The company is classified in the Healthcare sector and the Biotechnology industry.
Investors commonly review ALNY through its earnings trend, revenue, free cash flow, balance sheet, valuation and historical risk. Use the financial statements to check whether reported profit is supported by cash generation.